Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome December 17, 2024
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD) December 16, 2024
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell December 14, 2024
Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU December 10, 2024
IBPS SO Mains Admit Card 2024 released at ibps.in, exam on Dec 14: Direct link to download Phase 2 call letter here December 6, 2024
AP LAWCET phase 2 seat allotment results released at lawcet-sche.aptonline.in: Direct link to check here December 3, 2024
Bulletin from Extraordinary General Meeting of Phase Holographic Imaging PHI AB (publ) December 2, 2024
ExpreS2ion announces approval to initiate a Phase I clinical trial of ES2B-C001, its novel therapeutic vaccine, being developed for HER2-expressing breast cancer December 2, 2024
Celonis Appoints Benoit Fouilland as Chief Financial Officer to Drive Next Phase of Growth December 2, 2024
